| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs4073054 | X-10395 | A/C | 7340 | 0.63 | 0.016 (0.002) | 4.42·10-19 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs4073054 |
| Chromosomal location | Chr1: 159,467,111 (1q23.3) |
| Gene (distance) | NR1I3 (0) |
| Predicted causal gene | unknown |
| Gene/protein classification | drug target, metabolic enzyme, is a modulator |
| Metabolite (Pathway) | X-10395 (Unknown) |
| Biochemical locus-metabolite relationship | X-10395 is an unknown metabolite |
| eQTL associations | - |
| Medical information | |
|---|---|
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | CHEMBL5503 |
| Drug information | Meclizine is a modulator; Estradiol, Clotrimazoll are active; Phenobarbital is an indirect activator; Phenytoin is an indirect activator and Chlorpromazine is an inverse agonist (more details...) |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








